Ulf Tidefelt
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Oncology top 2%
- Neutropenia and Cancer Infections
- Drug Transport and Resistance Mechanisms
- Cancer-related Molecular Pathways
Papers in
- Hematology 29
- Acute Myeloid Leukemia Research 22
- Hematopoietic Stem Cell Transplantation 7
- Oncology 35
- Drug Transport and Resistance Mechanisms 9
- Cancer Treatment and Pharmacology 9
- Neutropenia and Cancer Infections 9
- Co-authors
- Christer PaulGunnar JuliussonLars MöllgårdMartin HöglundSylvain LehmannDick StockelbergAnders WåhlinÅsa Rangert Derolf
- Journals
- Leukemia Research (11 papers)European Journal Of Haematology (7 papers)Cancer Chemotherapy and Pharmacology (6 papers)Blood (5 papers)British Journal of Haematology (3 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Ulf Tidefelt
63 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Hematology 1.3k
- Oncology 989
- Genetics 301
- Public Health, Environmental and Occupational Health 561
- Molecular Biology 1.2k
Countries citing papers authored by Ulf Tidefelt
This map shows the geographic impact of Ulf Tidefelt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Tidefelt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Tidefelt more than expected).
Fields of papers citing papers by Ulf Tidefelt
This network shows the impact of papers produced by Ulf Tidefelt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Tidefelt. The network helps show where Ulf Tidefelt may publish in the future.
Co-authors
The 25 scholars most cited alongside Ulf Tidefelt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 33 | |
| 2 | 2011 | 20 | |
| 3 | Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry Hit paper breakdown → | 2008 | 683 |
| 4 | 2004 | 66 | |
| 5 | 2004 | 24 | |
| 6 | 2003 | 14 | |
| 7 | 2003 | 37 | |
| 8 | 2003 | 8 | |
| 9 | 2003 | 9 | |
| 10 | 2002 | 13 | |
| 11 | No additional toxicity from cladribine (CdA) when given with cytosin arabinoside and idarubicin (CCI) as primary treatment of acute myeloid leukemia in elderly patients : Results from a randomized phase II-study from the leukemia group of middle Sweden (LGMS). | 2001 | 3 |
| 12 | 2000 | 22 | |
| 13 | 1999 | 24 | |
| 14 | 1998 | 7 | |
| 15 | 1996 | 20 | |
| 16 | 1993 | 29 | |
| 17 | 1993 | 30 | |
| 18 | 1990 | 27 | |
| 19 | 1989 | 43 | |
| 20 | 1989 | 7 |
About Ulf Tidefelt
Ulf Tidefelt is a scholar working on Hematology, Oncology, Clinical Biochemistry, Genetics and Public Health, Environmental and Occupational Health, having authored 63 papers that have together received 2.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Acute Lymphoblastic Leukemia research (15 papers), Cancer therapeutics and mechanisms (13 papers), Drug Transport and Resistance Mechanisms (9 papers), Cancer Treatment and Pharmacology (9 papers), Neutropenia and Cancer Infections (9 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Bacterial Identification and Susceptibility Testing (6 papers). The work is most often cited by research in Hematology (1.3k citations), Oncology (989 citations), Genetics (301 citations), Public Health, Environmental and Occupational Health (561 citations) and Molecular Biology (1.2k citations). Ulf Tidefelt has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Christer Paul, Gunnar Juliusson, Lars Möllgård, Martin Höglund, Sylvain Lehmann, Dick Stockelberg, Anders Wåhlin, Åsa Rangert Derolf, Petar Antunović and Britt Sundman‐Engberg. Their work appears in journals such as Leukemia Research, European Journal Of Haematology, Cancer Chemotherapy and Pharmacology, Blood and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.